Tradestie Institutional Equity Comparison Engine
PACS vs SGRY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PACS Overall Edge
PACS Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PACS Group, Inc. (PACS) driven by superior Valuation, Growth & Margin, Options & Structure while SGRY counters with relative strength in Momentum & Technical. Fundamentally, PACS trades at 15.3x Forward P/E with 7.4% operating margin (+11.5% YoY revenue) versus SGRY at N/M Forward P/E and 13.2% operating margin (-0.8% YoY). In options structure, PACS sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro) against SGRY sits in SURGE (34th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
PACS
PACS 15.3x vs SGRY N/M Fwd P/E
Growth & Margin Winner
PACS
Op Margin 7.4% vs 13.2% ยท YoY +11.5% vs -0.8%
Momentum & Technical Winner
SGRY
1Y +159.5% vs +70.5% ยท 52W Pos 79% vs 97%
Options & Structure Winner
PACS
CONSOLIDATION (11th %ile IV) vs SURGE (34th %ile IV)
PACS
NYSE
PACS Group, Inc.
Services-Skilled Nursing Care Facilities
$43.67
+1.49% 1D
Market Cap
$6.8B
1M Return
-8.06%
1Y Return
+159.48%
Forward P/E
15.3x
Unified AI Score
46.8 / 100
HOLD
Tech 35.0
Fund 48.0
Flow 62.0
Mom 50.0
SGRY
NASDAQ
Surgery Partners, Inc. Common Stock
Services-General Medical & Surgical Hospitals, Nec
$26.78
+0.34% 1D
Market Cap
$3.5B
1M Return
+68.43%
1Y Return
+70.46%
Forward P/E
N/M
Unified AI Score
29.6 / 100
SELL
Tech 50.0
Fund 24.0
Flow 56.0
Mom 21.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PACS +159.48%
SGRY +70.46%
Spread: +89.02 pp (PACS Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PACS Revenue | SGRY Revenue | PACS Op. Margin | SGRY Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $1.77B | N/A | 4.4% | SGRY |
| FY2019 | N/A | $1.83B | N/A | 12.9% | SGRY |
| FY2020 | N/A | $1.86B | N/A | 9.8% | SGRY |
| FY2021 | N/A | $2.23B | N/A | 13.6% | SGRY |
| FY2022 | $2.40B | $2.54B | 9.6% | 13.6% | SGRY |
| FY2023 | $3.11B | $2.74B | 6.7% | 12.0% | SGRY |
| FY2024 | $4.09B | $3.11B | 3.0% | 11.2% | SGRY |
| FY2025 | $5.29B | $3.31B | 5.9% | 11.8% | SGRY |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PACS | SGRY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.8B | $3.5B | Larger Scale | PACS |
| Trailing P/E Ratio Valuation | 26.2x | N/M | Lower Multiple | PACS |
| Forward P/E Ratio Valuation | 15.3x | N/M | Lower Multiple | PACS |
| Revenue Growth (YoY) Growth | +11.5% | -0.8% | Higher Growth | PACS |
| Operating Margin (TTM) Profitability | 7.4% | 13.2% | Higher Margin | SGRY |
| Net Profit Margin Profitability | 4.9% | -2.6% | Higher Margin | PACS |
| Return on Equity (ROE) Capital Efficiency | 26.5% | 2.1% | Higher ROE | PACS |
| 52-Week Range Position Momentum | 79% ($14โ$52) | 97% ($11โ$27) | Stronger Trend | SGRY |
| Beta / 30D Volatility Risk Regime | 0.78ฮฒ ยท 51% Vol | 0.87ฮฒ ยท 166% Vol | Lower Realized Risk | PACS |
| Unified Institutional Score Composite Signal | 46.8 / 100 (HOLD) | 29.6 / 100 (SELL) | Higher Composite | PACS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PACS vs SGRY Buy Guide
PACS
CONSOLIDATION
83d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
11th %ile
IV Regime
Compressed (<25th %ile)
SGRY
SURGE
5d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
34th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PACS nor SGRY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.